Loading clinical trials...
Loading clinical trials...
Efficacy and Safety Analyses of Mirtazapine in the Treatment of Malignant Tumor Related Depression: A Phase II, Placebo-controlled, Randomized, Double-blinded Clinical Trial in Advanced Non-small Cell Lung Cancer Patients
Conditions
Interventions
Mirtazapine
Placebo
Locations
1
China
Cancer Center of Sun-Yat Sen University (CCSYSU)
Guangzhou, Guangdong, China
Start Date
December 1, 2015
Primary Completion Date
June 1, 2018
Completion Date
June 1, 2019
Last Updated
January 8, 2016
NCT07360600
NCT06793397
NCT07478393
NCT04165798
NCT06667908
NCT04123314
Lead Sponsor
Sun Yat-sen University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions